High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 2012-08, Vol.56 (8), p.4495-4499
Hauptverfasser: WROBLEWSKI, Heather A, KOVACS, Richard J, KINGERY, Joanna R, OVERHOLSER, Brian R, TISDALE, James E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4499
container_issue 8
container_start_page 4495
container_title Antimicrobial Agents and Chemotherapy
container_volume 56
creator WROBLEWSKI, Heather A
KOVACS, Richard J
KINGERY, Joanna R
OVERHOLSER, Brian R
TISDALE, James E
description Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
doi_str_mv 10.1128/AAC.06396-11
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_22615288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22615288</sourcerecordid><originalsourceid>FETCH-LOGICAL-a474t-78de5c0d083f30157fdc31e4cf324593c0b6b93ab6833ed544aa6df4be6063513</originalsourceid><addsrcrecordid>eNp1kU9vEzEQxS0EoqFw44zMgQMSW_w_3kulEAGtVERbpWdr1vYmLhu7sjep-lH6bXFIKXDgZI3fb954_BB6TckRpUx_nM3mR0TxVjWUPkETSlrdKNmqp2hCiFKN0EQcoBelXJNay5Y8RweMKSqZ1hN0fxKWK3wZyg-cenyxwKdx9HkLAz7PaUhxCWNIEUN0eJFyAecLdh6fp1C5gmelJBtg9A7fhnG1686w9TFtCr7YhBhciB5flar3KeNF9jCufRx3wy59CWWEWnyDAXIAXIlP0NXrVJWX6FkPQ_GvHs5DdPXl82J-0px9_3o6n501IKZibKbaeWmJI5r3nFA57Z3l1AvbcyZkyy3pVNdy6JTm3DspBIByvei8qr8mKT9Ex3vfm0239s763QqDuclhDfnOJAjmXyWGlVmmreGCUcVENfiwN7A5lZJ9_9hLidlFZGpE5ldEtaz4-z0OZc3MddrkWNf7H_vm77c9Gv_OrwLvHgAoFoY-Q7Sh_OEU1YROWeXe7rlVjfs2ZG_qdANgjVRGGyFayX8C8Dq0PQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>WROBLEWSKI, Heather A ; KOVACS, Richard J ; KINGERY, Joanna R ; OVERHOLSER, Brian R ; TISDALE, James E</creator><creatorcontrib>WROBLEWSKI, Heather A ; KOVACS, Richard J ; KINGERY, Joanna R ; OVERHOLSER, Brian R ; TISDALE, James E</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.06396-11</identifier><identifier>PMID: 22615288</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adolescent ; Adult ; Aged ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials ; Antimalarials - adverse effects ; Antimalarials - therapeutic use ; Arrhythmias, Cardiac ; Arrhythmias, Cardiac - chemically induced ; Babesiosis ; Babesiosis - drug therapy ; Babesiosis - physiopathology ; Biological and medical sciences ; Cardiac dysrhythmias ; Cardiology. Vascular system ; Clinical Therapeutics ; Female ; Heart ; Heart - drug effects ; Heart Rate - drug effects ; Human protozoal diseases ; Humans ; Infectious diseases ; Long QT Syndrome ; Long QT Syndrome - chemically induced ; Malaria ; Malaria - drug therapy ; Malaria - physiopathology ; Male ; Medical sciences ; Middle Aged ; Parasitic diseases ; Pharmacology. Drug treatments ; Protozoal diseases ; Quinidine ; Quinidine - adverse effects ; Quinidine - therapeutic use ; Risk Factors ; Torsades de Pointes ; Torsades de Pointes - chemically induced</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4495-4499</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a474t-78de5c0d083f30157fdc31e4cf324593c0b6b93ab6833ed544aa6df4be6063513</citedby><cites>FETCH-LOGICAL-a474t-78de5c0d083f30157fdc31e4cf324593c0b6b93ab6833ed544aa6df4be6063513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421624/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421624/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26180172$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22615288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WROBLEWSKI, Heather A</creatorcontrib><creatorcontrib>KOVACS, Richard J</creatorcontrib><creatorcontrib>KINGERY, Joanna R</creatorcontrib><creatorcontrib>OVERHOLSER, Brian R</creatorcontrib><creatorcontrib>TISDALE, James E</creatorcontrib><title>High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials</subject><subject>Antimalarials - adverse effects</subject><subject>Antimalarials - therapeutic use</subject><subject>Arrhythmias, Cardiac</subject><subject>Arrhythmias, Cardiac - chemically induced</subject><subject>Babesiosis</subject><subject>Babesiosis - drug therapy</subject><subject>Babesiosis - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology. Vascular system</subject><subject>Clinical Therapeutics</subject><subject>Female</subject><subject>Heart</subject><subject>Heart - drug effects</subject><subject>Heart Rate - drug effects</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Long QT Syndrome</subject><subject>Long QT Syndrome - chemically induced</subject><subject>Malaria</subject><subject>Malaria - drug therapy</subject><subject>Malaria - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Parasitic diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Protozoal diseases</subject><subject>Quinidine</subject><subject>Quinidine - adverse effects</subject><subject>Quinidine - therapeutic use</subject><subject>Risk Factors</subject><subject>Torsades de Pointes</subject><subject>Torsades de Pointes - chemically induced</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU9vEzEQxS0EoqFw44zMgQMSW_w_3kulEAGtVERbpWdr1vYmLhu7sjep-lH6bXFIKXDgZI3fb954_BB6TckRpUx_nM3mR0TxVjWUPkETSlrdKNmqp2hCiFKN0EQcoBelXJNay5Y8RweMKSqZ1hN0fxKWK3wZyg-cenyxwKdx9HkLAz7PaUhxCWNIEUN0eJFyAecLdh6fp1C5gmelJBtg9A7fhnG1686w9TFtCr7YhBhciB5flar3KeNF9jCufRx3wy59CWWEWnyDAXIAXIlP0NXrVJWX6FkPQ_GvHs5DdPXl82J-0px9_3o6n501IKZibKbaeWmJI5r3nFA57Z3l1AvbcyZkyy3pVNdy6JTm3DspBIByvei8qr8mKT9Ex3vfm0239s763QqDuclhDfnOJAjmXyWGlVmmreGCUcVENfiwN7A5lZJ9_9hLidlFZGpE5ldEtaz4-z0OZc3MddrkWNf7H_vm77c9Gv_OrwLvHgAoFoY-Q7Sh_OEU1YROWeXe7rlVjfs2ZG_qdANgjVRGGyFayX8C8Dq0PQ</recordid><startdate>20120801</startdate><enddate>20120801</enddate><creator>WROBLEWSKI, Heather A</creator><creator>KOVACS, Richard J</creator><creator>KINGERY, Joanna R</creator><creator>OVERHOLSER, Brian R</creator><creator>TISDALE, James E</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120801</creationdate><title>High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis</title><author>WROBLEWSKI, Heather A ; KOVACS, Richard J ; KINGERY, Joanna R ; OVERHOLSER, Brian R ; TISDALE, James E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a474t-78de5c0d083f30157fdc31e4cf324593c0b6b93ab6833ed544aa6df4be6063513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials</topic><topic>Antimalarials - adverse effects</topic><topic>Antimalarials - therapeutic use</topic><topic>Arrhythmias, Cardiac</topic><topic>Arrhythmias, Cardiac - chemically induced</topic><topic>Babesiosis</topic><topic>Babesiosis - drug therapy</topic><topic>Babesiosis - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology. Vascular system</topic><topic>Clinical Therapeutics</topic><topic>Female</topic><topic>Heart</topic><topic>Heart - drug effects</topic><topic>Heart Rate - drug effects</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Long QT Syndrome</topic><topic>Long QT Syndrome - chemically induced</topic><topic>Malaria</topic><topic>Malaria - drug therapy</topic><topic>Malaria - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Parasitic diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Protozoal diseases</topic><topic>Quinidine</topic><topic>Quinidine - adverse effects</topic><topic>Quinidine - therapeutic use</topic><topic>Risk Factors</topic><topic>Torsades de Pointes</topic><topic>Torsades de Pointes - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WROBLEWSKI, Heather A</creatorcontrib><creatorcontrib>KOVACS, Richard J</creatorcontrib><creatorcontrib>KINGERY, Joanna R</creatorcontrib><creatorcontrib>OVERHOLSER, Brian R</creatorcontrib><creatorcontrib>TISDALE, James E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WROBLEWSKI, Heather A</au><au>KOVACS, Richard J</au><au>KINGERY, Joanna R</au><au>OVERHOLSER, Brian R</au><au>TISDALE, James E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2012-08-01</date><risdate>2012</risdate><volume>56</volume><issue>8</issue><spage>4495</spage><epage>4499</epage><pages>4495-4499</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>22615288</pmid><doi>10.1128/AAC.06396-11</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4495-4499
issn 0066-4804
1098-6596
language eng
recordid cdi_pubmed_primary_22615288
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adolescent
Adult
Aged
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimalarials
Antimalarials - adverse effects
Antimalarials - therapeutic use
Arrhythmias, Cardiac
Arrhythmias, Cardiac - chemically induced
Babesiosis
Babesiosis - drug therapy
Babesiosis - physiopathology
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Clinical Therapeutics
Female
Heart
Heart - drug effects
Heart Rate - drug effects
Human protozoal diseases
Humans
Infectious diseases
Long QT Syndrome
Long QT Syndrome - chemically induced
Malaria
Malaria - drug therapy
Malaria - physiopathology
Male
Medical sciences
Middle Aged
Parasitic diseases
Pharmacology. Drug treatments
Protozoal diseases
Quinidine
Quinidine - adverse effects
Quinidine - therapeutic use
Risk Factors
Torsades de Pointes
Torsades de Pointes - chemically induced
title High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A29%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20Risk%20of%20QT%20Interval%20Prolongation%20and%20Torsades%20de%20Pointes%20Associated%20with%20Intravenous%20Quinidine%20Used%20for%20Treatment%20of%20Resistant%20Malaria%20or%20Babesiosis&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=WROBLEWSKI,%20Heather%20A&rft.date=2012-08-01&rft.volume=56&rft.issue=8&rft.spage=4495&rft.epage=4499&rft.pages=4495-4499&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.06396-11&rft_dat=%3Cpubmed_cross%3E22615288%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22615288&rfr_iscdi=true